Nicole Ngo-Giang-Huong

Summary

Affiliation: Harvard School of Public Health
Country: USA

Publications

  1. pmc Human immunodeficiency virus-hepatitis C virus co-infection in pregnant women and perinatal transmission to infants in Thailand
    Nicole Ngo-Giang-Huong
    Institut de recherche pour le developpement IRD, U174 Program for HIV Prevention and Treatment PHPT, Faculty of Associated Medical Sciences, Department of Medical Technology, 110 Inthawaroros Road, Muang, 50200 Chiang Mai, Thailand
    Int J Infect Dis 14:e602-7. 2010
  2. pmc Resistance patterns selected by nevirapine vs. efavirenz in HIV-infected patients failing first-line antiretroviral treatment: a bayesian analysis
    Nicole Ngo-Giang-Huong
    Institut de Recherche pour le Développement IRD UMI 174 PHPT, Marseilles, France
    PLoS ONE 6:e27427. 2011
  3. pmc Early HIV-1 diagnosis using in-house real-time PCR amplification on dried blood spots for infants in remote and resource-limited settings
    Nicole Ngo-Giang-Huong
    département Sociétés et Santé, Institut de Recherche pour le Developpement, U174 Program for HIV Prevention and Treatment, Chiang Mai, Thailand
    J Acquir Immune Defic Syndr 49:465-71. 2008
  4. ncbi request reprint Risk factors for in utero or intrapartum mother-to-child transmission of human immunodeficiency virus type 1 in Thailand
    Gonzague Jourdain
    Institut de Recherche pour le Developpement, UMI 174 Epidemiologie Clinique, Sante Maternelle et Infantile et Sida, Paris, France
    J Infect Dis 196:1629-36. 2007
  5. pmc The interrelated transmission of HIV-1 and cytomegalovirus during gestation and delivery in the offspring of HIV-infected mothers
    Woottichai Khamduang
    Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand
    J Acquir Immune Defic Syndr 58:188-92. 2011
  6. pmc Switching HIV treatment in adults based on CD4 count versus viral load monitoring: a randomized, non-inferiority trial in Thailand
    Gonzague Jourdain
    Unité Mixte Internationale 174, Institut de Recherche pour le Développement IRD Programs for HIV Prevention and Treatment PHPT, Chiang Mai, Thailand
    PLoS Med 10:e1001494. 2013
  7. pmc Association between detection of HIV-1 DNA resistance mutations by a sensitive assay at initiation of antiretroviral therapy and virologic failure
    Gonzague Jourdain
    Institut de Recherche pour le Developpement, UMI 174 PHPT, Thailand
    Clin Infect Dis 50:1397-404. 2010
  8. pmc Randomized noninferiority trial of two maternal single-dose nevirapine-sparing regimens to prevent perinatal HIV in Thailand
    Marc Lallemant
    aUnité Mixte Internationale 174, Institut de Recherche pour le Développement IRD PHPT, Chiang Mai, Thailand bDepartment of Immunology and Infectious, Diseases, Harvard School of Public Health, Boston, Massachusetts, USA cDepartment of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand dUnité Mixte de Recherche 196, Centre Français de la Population et du Développement, INED IRD Paris V University, Paris, France eDepartment of Statistics, Faculty of Science, Chiang Mai University, Chiang Mai fSanpatong Hospital, Ministry of Public Health, Sanpatong gSamutprakarn Hospital, Ministry of Public Health, Samutprakarn hBanglamung Hospital, Ministry of Public Health, Chonburi, Thailand iChildren s Hospital, Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA jFamily Health Research Center, Mahidol University, Bangkok, Thailand
    AIDS 29:2497-507. 2015
  9. pmc Analysis of residual perinatal transmission of hepatitis B virus (HBV) and of genetic variants in human immunodeficiency virus and HBV co-infected women and their offspring
    Woottichai Khamduang
    Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand INSERM U966, CHRU Tours, Faculte de Medecine, Universite Francois Rabelais, Tours, France Institut de Recherche pour le Développement IRD UMI 174 Programs for HIV Prevention and Treatment PHPT, Chiang Mai, Thailand
    J Clin Virol 58:415-21. 2013
  10. ncbi request reprint Higher placental anti-inflammatory IL-10 cytokine expression in HIV-1 infected women receiving longer zidovudine prophylaxis associated with nevirapine
    Sakorn Pornprasert
    Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand
    Curr HIV Res 7:211-7. 2009

Collaborators

Detail Information

Publications21

  1. pmc Human immunodeficiency virus-hepatitis C virus co-infection in pregnant women and perinatal transmission to infants in Thailand
    Nicole Ngo-Giang-Huong
    Institut de recherche pour le developpement IRD, U174 Program for HIV Prevention and Treatment PHPT, Faculty of Associated Medical Sciences, Department of Medical Technology, 110 Inthawaroros Road, Muang, 50200 Chiang Mai, Thailand
    Int J Infect Dis 14:e602-7. 2010
    ....
  2. pmc Resistance patterns selected by nevirapine vs. efavirenz in HIV-infected patients failing first-line antiretroviral treatment: a bayesian analysis
    Nicole Ngo-Giang-Huong
    Institut de Recherche pour le Développement IRD UMI 174 PHPT, Marseilles, France
    PLoS ONE 6:e27427. 2011
    ..We compared patterns of NNRTI- and NRTI-associated mutations in Thai adults failing first-line nevirapine- and efavirenz-based combinations, using bayesian statistics to optimize use of data...
  3. pmc Early HIV-1 diagnosis using in-house real-time PCR amplification on dried blood spots for infants in remote and resource-limited settings
    Nicole Ngo-Giang-Huong
    département Sociétés et Santé, Institut de Recherche pour le Developpement, U174 Program for HIV Prevention and Treatment, Chiang Mai, Thailand
    J Acquir Immune Defic Syndr 49:465-71. 2008
    ..In resource-limited settings, most perinatally HIV-1-infected infants do not receive timely antiretroviral therapy because early HIV-1 diagnosis is not available or affordable...
  4. ncbi request reprint Risk factors for in utero or intrapartum mother-to-child transmission of human immunodeficiency virus type 1 in Thailand
    Gonzague Jourdain
    Institut de Recherche pour le Developpement, UMI 174 Epidemiologie Clinique, Sante Maternelle et Infantile et Sida, Paris, France
    J Infect Dis 196:1629-36. 2007
    ..The identification of risk factors for in utero and intrapartum transmission of human immunodeficiency virus type 1 (HIV-1) is crucial to the design and understanding of preventive interventions...
  5. pmc The interrelated transmission of HIV-1 and cytomegalovirus during gestation and delivery in the offspring of HIV-infected mothers
    Woottichai Khamduang
    Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand
    J Acquir Immune Defic Syndr 58:188-92. 2011
    ..01), and overall HIV with overall CMV infection (P = 0.001), and prematurity (P = 0.004). Congenital and acquired CMV infections are strong independent correlates of mother-to-child HIV transmission...
  6. pmc Switching HIV treatment in adults based on CD4 count versus viral load monitoring: a randomized, non-inferiority trial in Thailand
    Gonzague Jourdain
    Unité Mixte Internationale 174, Institut de Recherche pour le Développement IRD Programs for HIV Prevention and Treatment PHPT, Chiang Mai, Thailand
    PLoS Med 10:e1001494. 2013
    ..The purpose of the study was to determine whether a CD4-based monitoring and switching strategy would provide a similar clinical outcome compared to the standard VL-based strategy in Thailand...
  7. pmc Association between detection of HIV-1 DNA resistance mutations by a sensitive assay at initiation of antiretroviral therapy and virologic failure
    Gonzague Jourdain
    Institut de Recherche pour le Developpement, UMI 174 PHPT, Thailand
    Clin Infect Dis 50:1397-404. 2010
    ..There is no simple and efficient method to detect such mutations at the initiation of ART...
  8. pmc Randomized noninferiority trial of two maternal single-dose nevirapine-sparing regimens to prevent perinatal HIV in Thailand
    Marc Lallemant
    aUnité Mixte Internationale 174, Institut de Recherche pour le Développement IRD PHPT, Chiang Mai, Thailand bDepartment of Immunology and Infectious, Diseases, Harvard School of Public Health, Boston, Massachusetts, USA cDepartment of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand dUnité Mixte de Recherche 196, Centre Français de la Population et du Développement, INED IRD Paris V University, Paris, France eDepartment of Statistics, Faculty of Science, Chiang Mai University, Chiang Mai fSanpatong Hospital, Ministry of Public Health, Sanpatong gSamutprakarn Hospital, Ministry of Public Health, Samutprakarn hBanglamung Hospital, Ministry of Public Health, Chonburi, Thailand iChildren s Hospital, Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA jFamily Health Research Center, Mahidol University, Bangkok, Thailand
    AIDS 29:2497-507. 2015
    ..Perinatal single-dose nevirapine (sdNVP) selects for resistance mutations. The objective of this trial was to compare two maternal sdNVP-sparing regimens with standard zidovudine (ZDV)/sdNVP prophylaxis...
  9. pmc Analysis of residual perinatal transmission of hepatitis B virus (HBV) and of genetic variants in human immunodeficiency virus and HBV co-infected women and their offspring
    Woottichai Khamduang
    Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand INSERM U966, CHRU Tours, Faculte de Medecine, Universite Francois Rabelais, Tours, France Institut de Recherche pour le Développement IRD UMI 174 Programs for HIV Prevention and Treatment PHPT, Chiang Mai, Thailand
    J Clin Virol 58:415-21. 2013
    ..Limited data are available on the residual MTCT of HBV in human immunodeficiency virus (HIV)-HBV co-infected women...
  10. ncbi request reprint Higher placental anti-inflammatory IL-10 cytokine expression in HIV-1 infected women receiving longer zidovudine prophylaxis associated with nevirapine
    Sakorn Pornprasert
    Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand
    Curr HIV Res 7:211-7. 2009
    ....
  11. doi request reprint New-Onset Diabetes and Antiretroviral Treatments in HIV-Infected Adults in Thailand
    Prakit Riyaten
    Department of Statistics, Faculty of Science, Chiang Mai University, Chiang Mai, Thailand Institut de recherche pour le développement IRD UMI 174 PHPT, Chiang Mai, Thailand Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA Nakornping Hospital, Chiang Mai, Thailand Prapokklao Hospital, Chantaburi, Thailand Chonburi Hospital, Chonburi, Thailand Chiangrai Prachanukroh Hospital, Chiang Rai, Thailand Hat Yai Hospital, Songkla, Thailand Nong Khai Hospital, Nong Khai, Thailand Samutsakhon Hospital, Samutsakhon, Thailand Mahasarakham Hospital, Mahasarakham, Thailand Sanpatong Hospital, Chiang Mai, Thailand Institut National d Etudes Démographiques, Paris, France Sorbonne Universités, INSERM UPMC UMR_S938, APHP, Univ Paris 06, Paris, EVMS/Division Infectious Diseases
    J Acquir Immune Defic Syndr 69:453-9. 2015
    ..We estimated the incidence of new-onset diabetes and assessed the association between individual ARVs and ARV combinations, and diabetes in a large cohort in Thailand...
  12. pmc Long-term hepatitis B virus (HBV) response to lamivudine-containing highly active antiretroviral therapy in HIV-HBV co-infected patients in Thailand
    Woottichai Khamduang
    Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand
    PLoS ONE 7:e42184. 2012
    ....
  13. pmc Influence of body weight on achieving indinavir concentrations within its therapeutic window in HIV-infected Thai patients receiving indinavir boosted with ritonavir
    Tim R Cressey
    Program for HIV Prevention and Treatment IRD URI 174, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand
    Ther Drug Monit 33:25-31. 2011
    ..The risk of toxic drug concentrations increases rapidly with IDV/r dose of 600/100 mg for patients less than 50 kg and therapeutic drug monitoring of IDV concentrations would help to reduce the risk of IDV-induced nephrotoxicity...
  14. pmc Laboratory and clinical predictors of disease progression following initiation of combination therapy in HIV-infected adults in Thailand
    Trinh Duong
    Institut de Recherche pour le Developpement, IRD UMI 174, Paris, France
    PLoS ONE 7:e43375. 2012
    ..Data on determinants of long-term disease progression in HIV-infected patients on antiretroviral therapy (ART) are limited in low and middle-income settings...
  15. doi request reprint Characteristics of HIV type 1 (HIV-1) glycoprotein 120 env sequences in mother-infant pairs infected with HIV-1 subtype CRF01_AE
    Tanawan Samleerat
    Faculty of Associated Medical Sciences, Chiang Mai University, Thailand
    J Infect Dis 198:868-76. 2008
    ..This finding was particularly significant for the PNGS at positions N301 and N384...
  16. pmc Pharmacokinetics and virologic response of zidovudine/lopinavir/ritonavir initiated during the third trimester of pregnancy
    Tim R Cressey
    Department of Medical Technology, Chiang Mai University, Thailand
    AIDS 24:2193-200. 2010
    ....
  17. pmc Efficacy and safety of 1-month postpartum zidovudine-didanosine to prevent HIV-resistance mutations after intrapartum single-dose nevirapine
    Marc Lallemant
    Institut de Recherche pour le Développement U174, Universite Paris Descartes, Institut National d Etudes Demographiques, Institut de Recherche pour le Developpment, F 75006, Paris, France
    Clin Infect Dis 50:898-908. 2010
    ..We hypothesized that a 1-month zidovudine-didanosine course initiated at the same time as single-dose nevirapine (sdNVP) would prevent the selection of nevirapine-resistance mutations...
  18. pmc Early postpartum pharmacokinetics of lopinavir initiated intrapartum in Thai women
    Tim R Cressey
    Harvard School of Public Health, Boston, Massachusetts, USA
    Antimicrob Agents Chemother 53:2189-91. 2009
    ..2 (8.0 to 17.5) microg/ml, and 4.6 (1.7 to 12.5) microg/ml, respectively, at 41 (12 to 74) h after delivery. All of the women attained adequate LPV levels through 30 days postpartum. No serious adverse events were reported...
  19. ncbi request reprint Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy
    Gonzague Jourdain
    Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, USA
    N Engl J Med 351:229-40. 2004
    ..Whether there are clinically significant consequences in mothers who are subsequently treated with a nevirapine-containing regimen is unknown...
  20. ncbi request reprint Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand
    Marc Lallemant
    Epidemiologie Clinique, Sante Maternelle et Infantile et Sida, Institut de Recherche pour le Developpement, Paris
    N Engl J Med 351:217-28. 2004
    ..We hypothesized that the administration, in addition to zidovudine, of a single dose of oral nevirapine to mothers during labor and to neonates would further reduce transmission of HIV...
  21. pmc Resistance detected by pyrosequencing following zidovudine monotherapy for prevention of HIV-1 mother-to-child-transmission
    Scott C Olson
    aUniversity of Washington bSeattle Children s Research Institute, Seattle, Washington, USA cInstitut de Recherche pour le Développement IRD UMI 174 PHPT, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand dHarvard School of Public Health, Boston, Massachusetts eTulane University School of Medicine, New Orleans, Louisiana, USA
    AIDS 29:1467-71. 2015
    ....